Is American Well (AMWL) Shares Surpassing Other Medical Stocks This Year?

How American Well Corporation Stacks Up Against Medical Sector Peers

For those interested in medical sector investments, identifying top performers is key. American Well Corporation (AMWL) is one such company that has caught the eye of many investors. But how does its recent performance measure up against the broader medical sector? By comparing AMWL’s year-to-date results with its industry counterparts, we can gain some insight.

AMWL operates within the medical sector, which is comprised of 926 publicly traded companies and currently holds the #9 spot in the Zacks Sector Ranking. This ranking system evaluates 16 sectors, ordering them from strongest to weakest based on the average Zacks Rank of their constituent companies.

The Zacks Rank system focuses on earnings forecasts and their revisions, aiming to identify stocks with improving profit outlooks. Historically, stocks with higher Zacks Ranks have outperformed the market over short-term periods. At present, American Well Corporation holds a Zacks Rank of #2 (Buy).

In the last quarter, analysts have raised their consensus estimate for AMWL’s annual earnings by 36.6%, signaling growing optimism about the company’s financial prospects.

According to the most recent data, AMWL’s share price has climbed approximately 14.3% since the start of the year. In contrast, the average stock in the medical sector has declined by about 1% over the same period. This indicates that AMWL is outpacing its sector peers in terms of returns so far this year.

Other Noteworthy Performers: Catalyst Pharmaceuticals

Catalyst Pharmaceuticals (CPRX) is another medical stock that has delivered positive results this year, achieving a 4.2% return since January.

For Catalyst Pharmaceuticals, the consensus earnings per share estimate for the current year has increased by 13% over the past three months. The stock currently boasts a Zacks Rank of #1 (Strong Buy).

Industry Breakdown

American Well Corporation is part of the Medical Info Systems industry, which consists of 42 companies and is currently ranked #138 by Zacks. On average, this group has seen an 18% decline in value this year, making AMWL’s positive performance stand out even more.

Meanwhile, Catalyst Pharmaceuticals belongs to the Medical - Drugs industry, which includes 143 stocks and is ranked #93. This industry has experienced a 2.7% decrease year-to-date.

Investors interested in the medical sector may want to keep a close watch on both American Well Corporation and Catalyst Pharmaceuticals as they continue to demonstrate strong performance.

Expert Stock Picks: Potential to Double

The Zacks research team has identified five stocks with the potential to gain 100% or more in the coming months. Among these, Director of Research Sheraz Mian has singled out one satellite-based communications company as having the highest upside. With the space industry expected to reach a trillion-dollar valuation and a rapidly expanding customer base, analysts predict a significant revenue surge for this company in 2025. While not every top pick achieves massive gains, this selection could outperform previous Zacks recommendations such as Hims & Hers Health, which soared by 209%.